Systematic Review of Available CAR-T Cell Trials around the World

SIMPLE SUMMARY: CAR-T cells are genetically modified T cells that are reprogrammed to specifically eliminate cancer cells. Due to its clinical success to treat certain hematological malignancies, novel approaches to improve CAR-T cell-based therapies are being explored. This systematic review gives...

Descripción completa

Detalles Bibliográficos
Autores principales: Barros, Luciana Rodrigues Carvalho, Couto, Samuel Campanelli Freitas, da Silva Santurio, Daniela, Paixão, Emanuelle Arantes, Cardoso, Fernanda, da Silva, Viviane Jennifer, Klinger, Paulo, Ribeiro, Paula do Amaral Costa, Rós, Felipe Augusto, Oliveira, Théo Gremen Mimary, Rego, Eduardo Magalhães, Ramos, Rodrigo Nalio, Rocha, Vanderson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179563/
https://www.ncbi.nlm.nih.gov/pubmed/35681646
http://dx.doi.org/10.3390/cancers14112667

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179563/
https://www.ncbi.nlm.nih.gov/pubmed/35681646
http://dx.doi.org/10.3390/cancers14112667

Ejemplares similares